\begin{landscape}
\begin{table}[H]
\centering
\footnotesize
\caption{Comparação entre resultados de \cite{ofori_2023} e cenários para os arquivos $Appenzeller-Herzog\_2020.csv$, $Bannach-Brown\_2019.csv$, $AtypicalAntipsychotics.csv$, $ACEInhibitors.csv$ e $OralHypoglycemics.csv$, das base de dados da Tabela \ref{tab:ec:source_input}.}
\label{tab:comparacao_real_vs_experimental}
\resizebox{1.5\textheight}{!}{%
\begin{tabular}{|p{4.5cm}|p{3.5cm}|c|c|c|c|c|c|c|c|c|c|}
\hline
\textbf{Arquivo} & \textbf{Modelo} & \textbf{TP} & \textbf{FP} & \textbf{TN} & \textbf{FN} & \textbf{N} & \textbf{P} & \textbf{Precision} & \textbf{Recall} & \textbf{F2} & \textbf{WSS95} \\ \hline
\multirow{5}{4em}{$Appenzeller-Herzog\_2020.csv$} & SVM com SDG e TF-IDF & 5 / 25 & 423 / 351 & 44 / 1981 & 0 / 1 & 472 / 2332 & 5 / 26 & 0.0117 / 0.0665 & 1.0000 / 0.9615 & 0.0558 / 0.2604 & 0.0428 / 0.7905 \\
 & Bi-LSTM com GloVe & 5 / 25 & 329 / 376 & 138 / 1956 & 0 / 1 & 472 / 2332 & 5 / 26 & 0.0150 / 0.0623 & 0.9615 / 0.9615 & 0.0705 / 0.2475 & 0.2425 / 0.7799 \\
 & LSTM com GloVe & 4 / 25 & 468 / 386 & 0 / 1946 & 0 / 1 & 472 / 2332 & 4 / 26 & 0.0081 / 0.0608 & 1.0000 / 0.9615 & 0.0390 / 0.2427 & -0.0500 / 0.7757 \\
 & Bi-LSTM com GloVe e Attention & 5 / 25 & 228 / 738 & 239 / 1594 & 0 / 1 & 472 / 2332 & 5 / 26 & 0.0215 / 0.0328 & 0.9615 / 0.9615 & 0.0986 / 0.1442 & 0.4566 / 0.6264 \\
 & LSTM com GloVe e Attention & 4 / 25 & 270 / 775 & 198 / 1557 & 0 / 1 & 472 / 2332 & 4 / 26 & 0.0132 / 0.0312 & 0.9474 / 0.9615 & 0.0623 / 0.1383 & 0.3701 / 0.6107 \\
\hline
\multirow{5}{4em}{$Bannach-Brown\_2019.csv$} & SVM com SDG e TF-IDF & 48 / 239 & 235 / 253 & 35 / 1095 & 2 / 12 & 320 / 1348 & 50 / 251 & 0.1690 / 0.4858 & 0.9522 / 0.9522 & 0.4942 / 0.7988 & 0.0657 / 0.6423 \\
 & Bi-LSTM com GloVe & 50 / 239 & 232 / 418 & 38 / 930 & 0 / 12 & 320 / 1348 & 50 / 251 & 0.1776 / 0.3638 & 0.9960 / 0.9522 & 0.5182 / 0.7194 & 0.0694 / 0.5391 \\
 & LSTM com GloVe & 50 / 239 & 270 / 433 & 0 / 915 & 0 / 12 & 320 / 1348 & 50 / 251 & 0.1570 / 0.3557 & 1.0000 / 0.9522 & 0.4821 / 0.7130 & -0.0500 / 0.5297 \\
 & Bi-LSTM com GloVe e Attention & 49 / 239 & 112 / 781 & 157 / 567 & 2 / 12 & 320 / 1348 & 51 / 251 & 0.3043 / 0.2343 & 0.9608 / 0.9522 & 0.6712 / 0.5904 & 0.4472 / 0.3121 \\
 & LSTM com GloVe e Attention & 48 / 239 & 190 / 500 & 80 / 848 & 2 / 12 & 320 / 1348 & 50 / 251 & 0.2034 / 0.3234 & 0.9641 / 0.9522 & 0.5515 / 0.6856 & 0.2058 / 0.4878 \\
\hline
\multirow{5}{4em}{$AtypicalAntipsychotics.csv$} & SVM com SDG e TF-IDF & 27 / 138 & 159 / 636 & 12 / 250 & 1 / 7 & 200 / 886 & 28 / 145 & 0.1467 / 0.1783 & 0.9514 / 0.9517 & 0.4536 / 0.5096 & 0.0151 / 0.1993 \\
 & Bi-LSTM com GloVe & 29 / 138 & 156 / 652 & 15 / 234 & 0 / 7 & 200 / 886 & 29 / 145 & 0.1558 / 0.1747 & 1.0000 / 0.9517 & 0.4800 / 0.5036 & 0.0251 / 0.1838 \\
 & LSTM com GloVe & 29 / 138 & 171 / 687 & 0 / 199 & 0 / 7 & 200 / 886 & 29 / 145 & 0.1441 / 0.1673 & 1.0000 / 0.9517 & 0.4571 / 0.4911 & -0.0500 / 0.1498 \\
 & Bi-LSTM com GloVe e Attention & 28 / 138 & 147 / 638 & 25 / 248 & 0 / 7 & 200 / 886 & 28 / 145 & 0.1579 / 0.1778 & 1.0000 / 0.9517 & 0.4839 / 0.5088 & 0.0751 / 0.1973 \\
 & LSTM com GloVe e Attention & 28 / 138 & 149 / 646 & 22 / 240 & 1 / 7 & 200 / 886 & 29 / 145 & 0.1590 / 0.1760 & 0.9792 / 0.9517 & 0.4819 / 0.5059 & 0.0621 / 0.1896 \\
\hline
\multirow{5}{4em}{$ACEInhibitors.csv$} & SVM com SDG e TF-IDF & 8 / 39 & 311 / 526 & 124 / 1668 & 0 / 2 & 443 / 2194 & 8 / 41 & 0.0239 / 0.0690 & 0.9500 / 0.9512 & 0.1084 / 0.2675 & 0.2305 / 0.6972 \\
 & Bi-LSTM com GloVe & 8 / 39 & 409 / 860 & 26 / 1334 & 0 / 2 & 443 / 2194 & 8 / 41 & 0.0187 / 0.0434 & 0.9750 / 0.9512 & 0.0869 / 0.1834 & 0.0092 / 0.5478 \\
 & LSTM com GloVe & 8 / 39 & 435 / 785 & 0 / 1409 & 0 / 2 & 443 / 2194 & 8 / 41 & 0.0181 / 0.0473 & 1.0000 / 0.9512 & 0.0842 / 0.1974 & -0.0500 / 0.5813 \\
 & Bi-LSTM com GloVe e Attention & 8 / 39 & 234 / 1213 & 202 / 981 & 0 / 2 & 443 / 2194 & 8 / 41 & 0.0311 / 0.0312 & 1.0000 / 0.9512 & 0.1382 / 0.1377 & 0.4057 / 0.3898 \\
 & LSTM com GloVe e Attention & 7 / 39 & 191 / 935 & 244 / 1259 & 1 / 2 & 443 / 2194 & 8 / 41 & 0.0364 / 0.0400 & 0.9000 / 0.9512 & 0.1565 / 0.1714 & 0.5028 / 0.5142 \\
\hline
\multirow{5}{4em}{$OralHypoglycemics.csv$} & SVM com SDG e TF-IDF & 25 / 126 & 61 / 292 & 5 / 51 & 1 / 6 & 92 / 343 & 26 / 132 & 0.2894 / 0.3014 & 0.9542 / 0.9545 & 0.6538 / 0.6660 & 0.0149 / 0.0700 \\
 & Bi-LSTM com GloVe & 26 / 126 & 60 / 315 & 5 / 28 & 1 / 6 & 92 / 343 & 27 / 132 & 0.3039 / 0.2857 & 0.9632 / 0.9545 & 0.6718 / 0.6502 & 0.0151 / 0.0216 \\
 & LSTM com GloVe & 26 / 126 & 66 / 284 & 0 / 59 & 0 / 6 & 92 / 343 & 26 / 132 & 0.2835 / 0.3073 & 1.0000 / 0.9545 & 0.6643 / 0.6716 & -0.0500 / 0.0868 \\
 & Bi-LSTM com GloVe e Attention & 26 / 126 & 44 / 314 & 22 / 29 & 0 / 6 & 92 / 343 & 26 / 132 & 0.3714 / 0.2864 & 1.0000 / 0.9545 & 0.7471 / 0.6508 & 0.1891 / 0.0237 \\
 & LSTM com GloVe e Attention & 23 / 126 & 35 / 308 & 31 / 35 & 3 / 6 & 92 / 343 & 26 / 132 & 0.3945 / 0.2903 & 0.8702 / 0.9545 & 0.7011 / 0.6549 & 0.3231 / 0.0363 \\
\hline
\end{tabular}
}
\normalsize
\end{table}
\end{landscape}